FDA Warning Letter — Kang Zhang, M.D., Ph.D.
The FDA took a Warning Letter action against Kang Zhang, M.D., Ph.D. on January 5, 2017 (La Jolla, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Kang Zhang, M.D., Ph.D.
- Date
- January 5, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- La Jolla, CA (United States)